Range Low Price High Price Comment
30 days $1.14 $1.32 Tuesday, 30th Apr 2024 ACRS stock ended at $1.21. This is 0.82% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 3.36% from a day low at $1.19 to a day high of $1.23.
90 days $1.05 $1.51
52 weeks $0.590 $11.12

Historical Aclaris Therapeutics prices

Date Open High Low Close Volume
Feb 02, 2016 $21.93 $21.93 $21.93 $21.93 11 300
Feb 01, 2016 $21.65 $21.65 $21.65 $21.65 31 300
Jan 29, 2016 $22.23 $22.23 $22.23 $22.23 42 700
Jan 28, 2016 $20.94 $20.94 $20.94 $20.94 26 400
Jan 27, 2016 $20.88 $20.88 $20.88 $20.88 27 900
Jan 26, 2016 $21.84 $21.84 $21.84 $21.84 38 900
Jan 25, 2016 $20.15 $20.15 $20.15 $20.15 28 300
Jan 22, 2016 $22.00 $22.00 $22.00 $22.00 40 900
Jan 21, 2016 $22.56 $22.56 $22.56 $22.56 31 000
Jan 20, 2016 $21.05 $21.05 $21.05 $21.05 36 500
Jan 19, 2016 $19.98 $19.98 $19.98 $19.98 34 000
Jan 15, 2016 $20.42 $20.42 $20.42 $20.42 49 500
Jan 14, 2016 $21.15 $21.15 $21.15 $21.15 30 700
Jan 13, 2016 $20.18 $20.18 $20.18 $20.18 60 700
Jan 12, 2016 $20.43 $20.43 $20.43 $20.43 68 800
Jan 11, 2016 $19.44 $19.44 $19.44 $19.44 95 800
Jan 08, 2016 $23.50 $23.50 $23.50 $23.50 19 700
Jan 07, 2016 $23.98 $23.98 $23.98 $23.98 26 800
Jan 06, 2016 $25.68 $25.68 $25.68 $25.68 41 200
Jan 05, 2016 $27.37 $27.37 $27.37 $27.37 42 800
Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT